Enhancing your customer engagement strategy with published content

Wednesday, July 27, 2022 | 11AM ET / 8AM PT / 4PM UK

Experts from Tangent90Veeva Systems and Compas, Inc. will discuss the following key topics, highlighting why they are an important part of your customer engagement strategy:

  • Global content strategies and how they are changing in a post-COVID era
    • Open access – what does it mean for Pharma
    • Dealing with copyright
    • Identifying content
  • Incorporating ePrints in your channel content
    • Understanding of an ePrint
    • The ePrint opportunity
    • What constitutes transfer of value (ToV) for ePrints
    • Does ToV apply if an HCP views content only?
  • How to achieve an omnichannel approach to content distribution
    • Volume – why delivering via Veeva Approved Email works
    • Embedding ePrints in your customer engagement and content strategy
    • How to drive adoption
    • Best practice examples and what not to do

For further information on the webinar or to find out more about how Tangent90 can support you to manage your scientific content distribution, please contact us at hello@tangent90.com.

Related news


Congresses are back but the focus has changed

As we slowly move on from the pandemic, we are seeing a return to in-person events. Our own research shows that 100% of the 65 medical congresses we have surveyed are providing in-person events, with 40% of those providing a hybrid solution. So how does the industry manage this dual approach? And how can we ensure we keep both audiences engaged?

Digital communication

Digital communication doesn’t need to cause ‘promo fatigue’

What have we learned from the last two years? We can share information, maintain HCP relationships, and drive acquisition, all via the click of a button. The world has well and truly embraced a digital-first approach but how do we ensure that we don’t overwhelm HCPs, simply because the method of communication is easier?


Seeing the Value of Scientific Content

In Pharmaceutical Commerce magazine, Tangent90 CEO Jan van den Burg discusses the value that HCPs place on scientific content and highlights the opportunity that pharma should be taking now.

Scroll to Top

Book A Demo

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.